154 related articles for article (PubMed ID: 27475862)
1. Roles of NTE protein and encoding gene in development and neurodevelopmental toxicity.
Sogorb MA; Pamies D; Estevan C; Estévez J; Vilanova E
Chem Biol Interact; 2016 Nov; 259(Pt B):352-357. PubMed ID: 27475862
[TBL] [Abstract][Full Text] [Related]
2. Effects of mipafox, paraoxon, chlorpyrifos and its metabolite chlorpyrifos-oxon on the expression of biomarker genes of differentiation in D3 mouse embryonic stem cells.
Sogorb MA; Fuster E; Del Río E; Estévez J; Vilanova E
Chem Biol Interact; 2016 Nov; 259(Pt B):368-373. PubMed ID: 27117976
[TBL] [Abstract][Full Text] [Related]
3. Silencing of PNPLA6, the neuropathy target esterase (NTE) codifying gene, alters neurodifferentiation of human embryonal carcinoma stem cells (NT2).
Pamies D; Bal-Price A; Fabbri M; Gribaldo L; Scelfo B; Harris G; Collotta A; Vilanova E; Sogorb MA
Neuroscience; 2014 Dec; 281():54-67. PubMed ID: 25255935
[TBL] [Abstract][Full Text] [Related]
4. Functional pathways altered after silencing Pnpla6 (the codifying gene of neuropathy target esterase) in mouse embryonic stem cells under differentiation.
Pamies D; Vilanova E; Sogorb MA
In Vitro Cell Dev Biol Anim; 2014 Mar; 50(3):261-73. PubMed ID: 24142151
[TBL] [Abstract][Full Text] [Related]
5. Expression of Neuropathy Target Esterase in mouse embryonic stem cells during differentiation.
Pamies D; Reig JA; Vilanova E; Sogorb MA
Arch Toxicol; 2010 Jun; 84(6):481-91. PubMed ID: 20112100
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity.
Ehrich M; Correll L; Veronesi B
Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605
[TBL] [Abstract][Full Text] [Related]
7. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
8. Reduction of neuropathy target esterase does not affect neuronal differentiation, but moderate expression induces neuronal differentiation in human neuroblastoma (SK-N-SH) cell line.
Chang PA; Chen R; Wu YJ
Brain Res Mol Brain Res; 2005 Nov; 141(1):30-8. PubMed ID: 16122834
[TBL] [Abstract][Full Text] [Related]
9. Neural development and neurodegeneration: two faces of neuropathy target esterase.
Glynn P
Prog Neurobiol; 2000 May; 61(1):61-74. PubMed ID: 10759065
[TBL] [Abstract][Full Text] [Related]
10. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
[TBL] [Abstract][Full Text] [Related]
11. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
Sogorb MA; González-González I; Pamies D; Vilanova E
Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
[TBL] [Abstract][Full Text] [Related]
12. NTE/PNPLA6 is expressed in mature Schwann cells and is required for glial ensheathment of Remak fibers.
McFerrin J; Patton BL; Sunderhaus ER; Kretzschmar D
Glia; 2017 May; 65(5):804-816. PubMed ID: 28206686
[TBL] [Abstract][Full Text] [Related]
13. Association of sick building syndrome with neuropathy target esterase (NTE) activity in Japanese.
Matsuzaka Y; Ohkubo T; Kikuti YY; Mizutani A; Tsuda M; Aoyama Y; Kakuta K; Oka A; Inoko H; Sakabe K; Ishikawa S; Kulski JK; Kimura M
Environ Toxicol; 2014 Oct; 29(10):1217-26. PubMed ID: 23418070
[TBL] [Abstract][Full Text] [Related]
14. Neuropathy target esterase (NTE): overview and future.
Richardson RJ; Hein ND; Wijeyesakere SJ; Fink JK; Makhaeva GF
Chem Biol Interact; 2013 Mar; 203(1):238-44. PubMed ID: 23220002
[TBL] [Abstract][Full Text] [Related]
15. In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate.
Fernandes LS; Emerick GL; dos Santos NA; de Paula ES; Barbosa F; dos Santos AC
Toxicol In Vitro; 2015 Apr; 29(3):522-8. PubMed ID: 25596135
[TBL] [Abstract][Full Text] [Related]
16. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ
J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of neuropathy target esterase activity in bovine chromaffin cell cultures by adenovirus-mediated gene transfer.
Quesada E; Castell JV; Vilanova E; Carrera V
Toxicol Lett; 2007 Feb; 168(3):286-91. PubMed ID: 17184936
[TBL] [Abstract][Full Text] [Related]
18. NTE and non-NTE esterases in brain membrane: kinetic characterization with organophosphates.
Mangas I; Vilanova E; Estévez J
Toxicology; 2012 Jul; 297(1-3):17-25. PubMed ID: 22503708
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon.
Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC
Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916
[TBL] [Abstract][Full Text] [Related]
20. Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances.
Johnson MK; Glynn P
Toxicol Lett; 1995 Dec; 82-83():459-63. PubMed ID: 8597094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
